LipoDox

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1994-2017
02419942017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
BACKGROUND The objective of this study was to evaluate the in vivo growth inhibition activity and tumor distribution of Doxil… (More)
Is this relevant?
2016
2016
BACKGROUND In response to the critical shortage of liposomal doxorubicin (Doxil®) in the United States, the Food and Drug… (More)
  • table 1
  • table 2
Is this relevant?
2015
2015
Due to the inability of classical chemotherapeutic agents to exclusively target tumor cells, these treatments are associated with… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2014
2014
Multidrug resistance (MDR) is a hallmark of cancer cells and a crucial factor in chemotherapy failure, cancer reappearance, and… (More)
Is this relevant?
2014
2014
It is hypothesized that the use of targeted drug delivery systems can significantly improve the therapeutic index of small… (More)
  • table I
  • figure 1
  • figure 2
  • figure 3
  • table II
Is this relevant?
2013
2013
Doxorubicin-loaded PEGylated liposomes (commercially available as DOXIL or Lipodox) were surface functionalized with a cell… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2012
2012
The present study explores the potential of polyelectrolyte-coated liposomes for improving the oral deliverability of doxorubicin… (More)
  • table 1
  • table 3
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2011
2011
The most frequent drawback of doxorubicin is the onset of drug resistance, due to the active efflux through P-glycoprotein (Pgp… (More)
Is this relevant?
2006
2006
OBJECTIVES To evaluate the efficacy and safety of a distearoylphosphatidylcholine pegylated liposomal doxorubicin, Lipo-Dox, in… (More)
Is this relevant?
1994
1994
Fourteen patients with advanced renal cell carcinoma were treated on a phase II trial with liposomal encapsulated doxorubicin… (More)
  • table 1
Is this relevant?